ERBB2 and breast cancer: In this issue of the Arab Journal of Urology, Agrawal et al. [5] explored the prognostic and therapeutic potential of a third biomarker for BC: the human epidermal growth factor receptor 2 (HER2), a tyrosine kinase transmembrane receptor involved in cycle cell regulation and cell proliferation.